Citigroup Increases Teladoc Health (NYSE:TDOC) Price Target to $7.00

Teladoc Health (NYSE:TDOC) had its price objective boosted by Citigroup from $6.00 to $7.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has a “neutral” rating on the health services provider’s stock. Citigroup’s price objective would indicate a potential upside of 3.95% from the stock’s previous close.

A number of other analysts have also issued reports on the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of Teladoc Health in a report on Friday, March 27th. JPMorgan Chase & Co. reduced their price objective on Teladoc Health from $9.00 to $7.00 and set a “neutral” rating on the stock in a report on Friday, March 13th. Stifel Nicolaus decreased their target price on Teladoc Health from $8.00 to $6.00 and set a “hold” rating for the company in a research report on Thursday, February 26th. Piper Sandler reiterated an “overweight” rating and issued a $9.00 target price (down from $12.00) on shares of Teladoc Health in a report on Thursday, February 26th. Finally, BMO Capital Markets cut their price target on Teladoc Health from $8.00 to $5.00 and set a “market perform” rating on the stock in a research note on Thursday, February 26th. Five analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $7.53.

Teladoc Health Trading Up 1.6%

Shares of NYSE:TDOC traded up $0.10 on Tuesday, hitting $6.73. 2,187,717 shares of the company’s stock were exchanged, compared to its average volume of 5,977,283. The stock has a market capitalization of $1.22 billion, a price-to-earnings ratio of -6.94 and a beta of 2.08. Teladoc Health has a 12 month low of $4.40 and a 12 month high of $9.77. The business’s 50 day simple moving average is $5.40 and its two-hundred day simple moving average is $6.43. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.80 and a quick ratio of 2.72.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, April 29th. The health services provider reported ($0.36) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.01). The company had revenue of $613.85 million for the quarter, compared to the consensus estimate of $611.04 million. Teladoc Health had a negative net margin of 6.81% and a negative return on equity of 11.45%. The company’s quarterly revenue was down 2.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.53) EPS. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. Analysts anticipate that Teladoc Health will post -0.89 EPS for the current fiscal year.

Insiders Place Their Bets

In other Teladoc Health news, CEO Charles Divita III sold 27,731 shares of the company’s stock in a transaction on Wednesday, March 11th. The stock was sold at an average price of $5.49, for a total transaction of $152,243.19. Following the completion of the sale, the chief executive officer owned 364,784 shares in the company, valued at $2,002,664.16. This represents a 7.06% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.70% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Teladoc Health

A number of hedge funds have recently made changes to their positions in the stock. IFP Advisors Inc boosted its position in Teladoc Health by 412.1% during the third quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock valued at $31,000 after purchasing an additional 3,210 shares in the last quarter. PNC Financial Services Group Inc. raised its holdings in Teladoc Health by 177.7% in the fourth quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock worth $31,000 after purchasing an additional 2,810 shares in the last quarter. Aster Capital Management DIFC Ltd lifted its position in shares of Teladoc Health by 101.1% during the third quarter. Aster Capital Management DIFC Ltd now owns 4,823 shares of the health services provider’s stock valued at $37,000 after buying an additional 2,425 shares during the last quarter. International Assets Investment Management LLC purchased a new stake in shares of Teladoc Health during the fourth quarter valued at about $45,000. Finally, Bayforest Capital Ltd bought a new stake in shares of Teladoc Health in the 3rd quarter valued at about $58,000. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.